Multi-country rapid adverse drug event assessment: The Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 9, 2013, Pages 915-924

  Pratt, Nicole ^a   Andersen, Morten ^b   Bergman, Ulf ^b   Choi, Nam Kyong ^c   Gerhard, Tobias ^d,e   Huang, Cecilia ^d   Kimura, Michio ^f   Kimura, Tomomi ^f   Kubota, Kiyoshi ^g   Lai, Edward Chia Cheng ^h   Ooba, Nobuhiro ^g   Ösby, Urban ⁱ   Park, Byung Joo ^c,j   Sato, Tsugumichi ^g   Shin, Ju Young ^c   Sundström, Anders ^b   Yang, Yea Huei Kao ^h   Roughead, Elizabeth E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Seoul National University College of Medicine   (South Korea)

^d RUTGERS UNIVERSITY   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j Seoul National University Hospital   (South Korea)

more..

Author keywords

Antipsychotics; Asian Pharmacoepidemiology Network (AsPEN); Distributed network model; Hyperglycaemial; Multi national collaboration; Pharmacoepidemiology; Prescription sequence symmetry analysis

Indexed keywords

HALOPERIDOL; INSULIN; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ARTICLE; AUSTRALIA; DRUG USE; HUMAN; HYPERGLYCEMIA; JAPAN; KOREA; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; TAIWAN; TREND STUDY; UNITED STATES;

ANTIPSYCHOTICS; ASIAN PHARMACOEPIDEMIOLOGY NETWORK (ASPEN); DISTRIBUTED NETWORK MODEL; HYPERGLYCAEMIAL; MULTI-NATIONAL COLLABORATION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION SEQUENCE SYMMETRY ANALYSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIPSYCHOTIC AGENTS; AUSTRALIA; DRUG PRESCRIPTIONS; FAR EAST; HUMANS; HYPERGLYCEMIA; NEURAL NETWORKS (COMPUTER); PHARMACOEPIDEMIOLOGY; SWEDEN; UNITED STATES;

EID: 84882626723     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3440     Document Type: Article

References (34)

1. AsPEN Collaborators. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf 2013; doi: 10.1002/pds.3439.
2. Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in europe to allow for large-scale drug safety monitoring: The EU-ADR project. Pharmacoepidemiol Drug Saf 2011; 20: 1-11.
3. Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the sentinel system--a national resource for evidence development. N Engl J Med 2011; 364: 498-499.
4. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7(5): 478-484.
5. Petri H, de Vet HC, Naus J, Urquhart J. Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med 1988; 7: 1171-1175.
6. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009; 18: 483-491.
7. Maclure M, Fireman B, Nelson JC, et al. When should case-only designs be used for safety monitoring of medical products? Pharmacoepidemiol Drug Saf 2012; 21(Suppl 1): 50-61.
8. Kim SM, Lee JS, Lee J, et al. Prevalence of Diabetes and Impaired Fasting Glucose in Korea. Diabetes Care 2006; 29(2): 226-231.
9. The DECODA Study Group. Age- and Sex-Specific Prevalence of Diabetes and Impaired Glucose Regulation in 11 Asian Cohorts. Diabetes Care 2003; 26(6): 1770-1780.
10. Kohen I, Gampel M, Reddy L, Manu P. Rapidly developing hyperglycemia during treatment with olanzapine. Ann Pharmacother 2008; 42(4): 588-591.
11. Lipscombe LL, Levesque L, Gruneir A, et al. Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med 2009; 169(14): 1282-1289.
12. Lipscombe LL, Levesque LE, Gruneir A, et al. Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: a population-based observational study. Am J Geriatr Psychiatry 2011; 19(12): 1026-1033.
13. Varma MK, Connolly K, Fulton B. Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature. J Intensive Care Med 2007; 22(1): 52-55.
14. Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K. First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2008; 192(6): 406-411.
15. Savoy YE, Ashton MA, Miller MW, et al. Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation. Schizophr Bull 2010; 36(2): 410-418.
16. Komossa K, Rummel-Kluge C, Hunger H, et al. Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010(3): CD006654.
17. Data Management and Information Systems, Department of Veterans' Affairs, Canberra, Australia.
18. Japan Medical Data Center database: Claims data assembled from a couple of private health insurance unions, Japan. http://www.jmdc.co.jp/en/mission/index.html (last accessed 22 October 2012).
19. Watanabe H, Kimura T, Hori K, Kawakami J, Kimura M. [D{star, open}D: Analytical clinical information retrieval system based on hospital information system - overview and use cases.] Jpn J Pharmacoepidemiol. 2010; 15(2): 97-106. (In Japanese)
20. Kimura M, et al. High speed clinical data retrieval system with event time sequence feature - with 10 years of clinical data of Hamamatsu University Hospital CPOE. Methods Inf Med 2008; 47(6): 560-568.
21. Korea Health Insurance Review and Assessment Service (HIRA). Major Activities of HIRA. HIRA, Seoul; March 2007. http://hira.or.kr/cms/rb/rbb_english/13/13_01/01/review.html (last accessed 22 October 2012).
22. Korea National Health Insurance Corporation (NHIC). Statistical Information. NHIC, Seoul; March 2010. http://stat.kosis.kr/nsieu/view/tree.do?task=branchView&id=350_35001_B*MT_OTITLE&hOrg=350 (last accessed 22 October 2012).
23. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16(7): 726-735.
24. National Health Insurance Research Database (NHIRD). Taiwan. http://www.nhri.org.tw/nhird/en/index.htm (last accessed 22 October 2012)
25. Crystal S, Akincigil A, Bilder S, Walkup JT. Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies. Med Care 2007; 45(10 Supl 2): S58-65.
26. Centers for Medicare and Medicaid Services. Medicaid Analytic eXtract (MAX) General Information. http://www.cms.gov/MedicaidDataSourcesGenInfo/07_MAXGeneralInformation.asp. (last accessed 22 October 2012).
27. Adamson DM, Chang S, Hansen LG. White Paper: Health Research Data for the Real 1World: the MarketScan Databases. Atlanta, GA: Thomson Medstat; 2006.
28. Koro CE, Fedder DO, L'Italien GJ, et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case control study. BMJ 2002; 325(7358): 243-247.
29. Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims. Pharmacoepidemiol Drug Saf 2005; 14(6): 417-425.
30. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19(Suppl 1): 1-93.
31. Center for Mental Health Services. Mental Health, United States, 2004. Manderscheid, R.W., and Berry, J.T., eds. DHHS Pub no. (SMA)-06-4195. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2006.
32. Trifiro G, Spina E, Gambassi G. Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? Pharmacol Res 2009; 59(1): 1-12.
33. Kim YJ, Kim G, Hansen L, Chiriboga D. Attitudes of Older Korean Americans Toward Mental Health Services. J Am Geriatr Soc 2007; 55(4); 616-620.
34. Miller MO. Evaluation and management of delirium in hospitalized older patients. Am Fam Physician 2008; 78(11): 1265-1270.